ASX Share rice
Mon 28 Sep 2020 - 08:53:am (Sydney)

OCC Share Price

ORTHOCELL LIMITEDOCCPharmaceuticals, Biotechnology & Life Sciences

OCC Company Information

Name:

Orthocell Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

Murdoch University Murdoch WA Australia 6150

Phone:

61 8 9360 2888

Exec. Chairman:

Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.

CEO, MD & Exec. Director:

Mr. Paul Anderson

Exec. Director:

Ms. Leslie Wise J.D.

Chief Financial Officer:

Ms. Nicole Jane Telford

Chief Operating Officer:

Mr. Alex McHenry

Company Overview:

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.

OCC Share Price Information

Shares Issued:

184.79M

Market Capitalisation:

$73.91M

Revenue (TTM):

$719.52K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.049

Operating Margin (TTM):

$-12.75

Return On Assets (TTM):

$-0.31

Return On Equity (TTM):

$-0.39

Quarterly Revenue Growth (YOY):

-0.199

Gross Profit(TTM):

$214.15K

Diluted Earnings Per Share (TTM):

$-0.036

OCC CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-55,198

Change To Liabilities:

$-750,615

Total Cashflow From Investing Activities:

$-55,200

Net Income:

$-6,151,029

Total Cash From Operating Activities:

$-5,256,870

Sale Purchase Of Stock:

$14.42M

Capital Expenditures:

$55.20K

OCC Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-9,055,580

Net Income:

$-6,151,030

Gross Profit:

$330.54K

Operating Income:

$-9,055,570

Other Operating Expenses:

$-82,940

Income Tax Expense:

$-2,904,546

Total Revenue:

$835.91K

Cost Of Revenue:

$505.37K

OCC Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$1.63M

Total Liabilities:

$2.27M

Total Stockholder Equity:

$20.90M

Other Current Liabilities:

$334.67K

Total Assets:

$23.17M

Common Stock:

$53.67M

Other Current Assets:

$63.09K

Retained Earnings:

$-32,771,280

Other Liabilities:

$13.22K

Cash:

$20.44M

Total Current Liabilities:

$1.86M

Property - Plant & Equipment:

$735.54K

Net Tangible Assets:

$19.27M

Total Current Assets:

$20.81M

Net Receivables:

$253.11K

Short-Term Investments:

$2.37M

Inventory:

$47.55K

Accounts Payable:

$790.09K

Non Currrent Assets (Other):

$-1

Short-Term Investments:

$2.37

Non Current Liabilities Total:

$406.47K

OCC Share Price History

OCC News

18 May, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
18 Feb, 2020
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
19 Nov, 2019
If you want to know who really controls Orthocell Limited (ASX:OCC), then you'll have to look at the makeup of its...
04 Oct, 2019
Paul Anderson is the CEO of Orthocell Limited (ASX:OCC). This analysis aims first to contrast CEO compensation with...